|
|
||||||||
Clinical Chemistry, Vol 39, 380-385, Copyright © 1993 by American Association for Clinical Chemistry
AH van Gennip, S Busch, L Elzinga, AE Stroomer, A van Cruchten, EG Scholten and NG Abeling
Academic Medical Center, Division of Pediatrics, Amsterdam, The Netherlands.
Recent findings suggest that inborn errors of pyrimidine catabolism are less rare than generally assumed. We propose a complete set of diagnostic methods for these disorders, suitable for the clinical chemistry laboratory, and present relevant reference data. Applications of thin-layer chromatography, high-performance liquid chromatography, and conventional cation-exchange amino acid analysis lead to detection of various defects in pyrimidine degradation, including the recently described deficiencies of dihydropyrimidine dehydrogenase and dihydropyrimidinase. We also illustrate the potential of the methods to analyze for the catabolites expected to be increased in the urine of patients with ureidopropionase deficiency. Possible pitfalls in the diagnosis and ways to prevent misdiagnosis are demonstrated. The methods offer possibilities for clinical chemistry laboratories to extend their diagnostic capacity to the new area of pyrimidine degradation defects.
The following articles in journals at HighWire Press have cited this article:
![]() |
A. B. P. van Kuilenburg, E. W. Muller, J. Haasjes, R. Meinsma, L. Zoetekouw, H. R. Waterham, F. Baas, D. J. Richel, and A. H. van Gennip Lethal Outcome of a Patient with a Complete Dihydropyrimidine Dehydrogenase (DPD) Deficiency after Administration of 5-Fluorouracil: Frequency of the Common IVS14+1G>A Mutation Causing DPD Deficiency Clin. Cancer Res., May 1, 2001; 7(5): 1149 - 1153. [Abstract] [Full Text] |
||||
![]() |
H. van Lenthe, A. B.P. van Kuilenburg, T. Ito, A. H. Bootsma, A. van Cruchten, Y. Wada, and A. H. van Gennip Defects in Pyrimidine Degradation Identified by HPLC-Electrospray Tandem Mass Spectrometry of Urine Specimens or Urine-soaked Filter Paper Strips Clin. Chem., December 1, 2000; 46(12): 1916 - 1922. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ito, A. B.P. van Kuilenburg, A. H. Bootsma, A. J. Haasnoot, A. van Cruchten, Y. Wada, and A. H. van Gennip Rapid Screening of High-Risk Patients for Disorders of Purine and Pyrimidine Metabolism Using HPLC-Electrospray Tandem Mass Spectrometry of Liquid Urine or Urine-soaked Filter Paper Strips Clin. Chem., April 1, 2000; 46(4): 445 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B.P. Van Kuilenburg, H. Van Lenthe, A. Tromp, P. C.J. Veltman, and A. H. Van Gennip Pitfalls in the Diagnosis of Patients with a Partial Dihydropyrimidine Dehydrogenase Deficiency Clin. Chem., January 1, 2000; 46(1): 9 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Y. Ahmed, S. J. Johnston, J. Cassidy, T. O'Kelly, N. Binnie, G. I. Murray, A. H. van Gennip, N. G.G.M. Abeling, S. Knight, and H. L. McLeod Eniluracil Treatment Completely Inactivates Dihydropyrimidine Dehydrogenase in Colorectal Tumors J. Clin. Oncol., August 1, 1999; 17(8): 2439 - 2439. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Wevers, U. F.H. Engelke, S. H. Moolenaar, C. Brautigam, J. G.N. de Jong, R. Duran, R. A. de Abreu, and A. H. van Gennip 1H-NMR Spectroscopy of Body Fluids: Inborn Errors of Purine and Pyrimidine Metabolism Clin. Chem., April 1, 1999; 45(4): 539 - 548. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |